Brief: SkinBioTherapeutics Appoints Rachel Parsonage, Interim CEO, To Board Of Directors
09/03/2026 07:22
March 9 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS - APPOINTMENT OF THE INTERIM CEO TO THE BOARD SKINBIOTHERAPEUTICS PLC - APPOINTS RACHEL PARSONAGE, INTERIM CEO, TO BOARD OF DIRECTORS Source text: ID:nRSI7635Va Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company